Versions Compared


  • This line was added.
  • This line was removed.
  • Formatting was changed.


Download the PDF: Muniyappa_Gubbi_oral_history (114 kB)

Read the papers:
"Catecholamine physiology and its implications in patients with COVID-19," Sriram Gubbi, Matthew A. Nazari, David Taieb, Joanna Klubo-Gwiezdzinska, and Karel Pacak, Lancet Diabetes Endocrinol. 2020 Dec; 8(12): 978–986.

"COVID-19 pandemic, coronaviruses, and diabetes mellitus," Ranganath Muniyappa and Sriram Gubbi, Am J Physiol Endocrinol Metab. 2020 May 1; 318(5): E736–E741.

"Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course," Rashika Bansal, Sriram Gubbi, and Ranganath Muniyappa, Endocrinology. 2020 Oct; 161(10): bqaa112.

"Diabetes, Obesity, and Risk Prediction of Severe COVID-19," Ranganath Muniyappaand Kenneth J Wilkins, J Clin Endocrinol Metab. 2020 Oct; 105(10): dgaa442.

"A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic," Mary Korytkowski, Kellie Antinori-Lent, Andjela Drincic, Irl B Hirsch, Marie E McDonnell, Robert Rushakoff, and Ranganath Muniyappa, J Clin Endocrinol Metab. 2020 Jun 4 : dgaa342. 

Dr. Ranganath Muniyappa and Dr. Sriram Gubbi